Advertisement
Screener

ENDONOVO THERAPEUTICS, INC. (ENDV) APIC, Share-based Payment Arrangement, Increase for Cost Recognition

1.6 / 5 stars · 18/56 Roast Me

ENDONOVO THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition

ENDONOVO THERAPEUTICS, INC. (ENDV) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $6.03 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.

Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition

us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2023-08-21

  • ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $6.03K.
  • ENDONOVO THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2021-09-30 was $20.49K.
Period endAPIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month
2023-06-30$6.03K
10-Q · filed 2023-08-21
2021-09-30$20.49K
10-Q · filed 2022-11-21